Growth of the AI-Powered Pathology Analysis Systems Market
Thanks to medical imaging, precision medicine, and rising cancer cases, AI-powered pathology systems are expanding rapidly.
The global artificial intelligence-powered pathology analysis systems market continues to grow in line with advancements in medical imaging technologies and rising cancer cases, advancing toward a target of $153.02 billion by 2030.
Global Market Size and Trajectory
The global artificial intelligence-powered pathology analysis systems market rose from $66.06 billion in 2025 to $78.02 billion in 2026.
The market is projected to reach a size of $153.02 billion by 2030.
Key Factors Driving the Market
This rapid growth in the sector is supported by rising cancer cases, shortages of pathologists, and advancements in artificial intelligence algorithms.
Additionally, the expansion of precision medicine applications and the adoption of cloud-based health data ecosystems are accelerating the process.
Sector Developments and Acquisitions
In April 2025, Paige.AI received FDA Breakthrough Device Designation for its Paige PanCancer Detect application.
In May 2026, Grundium Oy acquired Visiopharm A/S to integrate AI-powered precision pathology software.
Cancer Cases and Regional Distribution
According to data from Macmillan Cancer Support, more than 3 million people were living with cancer in the UK in 2024, and this number is expected to grow.
While North America held the largest market position in 2025, the Asia-Pacific region is expected to register the fastest growth.